COVID-19: Hydroxychloroquine-Remdesivir comparison not right at this moment, says CSIR

  • 4 years ago
Council of Scientific & Industrial Research (CSIR) Director General Shekhar C Mande said that it is very difficult to compare the efficacy of hydroxychloroquine and remdesivir as of now. “Comparison between hydroxychloroquine & remdesivir is not right because we do not know the efficacy of both of them till now. Which one is better can only be ascertained after trials,” said Dr Mande.

Recommended